Using CRISPR to detect cancer biomarkers

Most cancer diagnostic techniques rely on uncomfortable and invasive procedures, such as biopsies, endoscopies or mammograms. Blood samples could be a less unpleasant option, though only a few forms of the disease can currently be diagnosed this way. But now, researchers have developed an easy-to-use method that can detect small amounts of cancer-related molecules in exosomes in plasma and effectively distinguish between malignant and benign samples.

Source: sciencedaily.com

Related posts

Sweet taste receptor affects how glucose is handled metabolically by humans

How heatwaves are affecting Arctic phytoplankton

Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses